Author:
Nanos-Webb A,Bui T,Karakas C,Zhang D,Carey J P W,Mills G B,Hunt K K,Keyomarsi K
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference43 articles.
1. Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res 2004; 10: 2473–2481.
2. Tan DS, Rothermundt C, Thomas K, Bancroft E, Eeles R, Shanley S et al. “BRCAness” syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol 2008; 26: 5530–5536.
3. Farley J, Smith LM, Darcy KM, Sobel E, O'Connor D, Henderson B et al. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study. Cancer Res 2003; 63: 1235–1241.
4. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002; 347: 1566–1575.
5. Bedrosian I, Lu KH, Verschraegen C, Keyomarsi K . Cyclin E deregulation alters the biologic properties of ovarian cancer cells. Oncogene 2004; 23: 2648–2657.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献